|
Albrecht, G.J., Hochstrasser, K. and Salier, J.P. (1983) Elastase inhibition by the inter-alpha-trypsin inhibitor and derived inhibitors of man and cattle. Hoppe Seylers Z Physiol Chem, 364, 1703-1708.
Andreasen, P.A., Kjoller, L., Christensen, L. and Duffy, M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer, 72, 1-22.
Balduyck, M., Davril, M., Mizon, C., Smyrlaki, M., Hayem, A. and Mizon, J. (1985) Human urinary proteinase inhibitor: inhibitory properties and interaction with bovine trypsin. Biol Chem Hoppe Seyler, 366, 9-14.
Balduyck, M., Hayem, A., Kerckaert, J.P., Mizon, C. and Mizon, J. (1982) Isolation of a human urinary trypsin inhibitor. Biochem Biophys Res Commun, 109, 1247-1255.
Brizel, D.M., Scully, S.P., Harrelson, J.M., Layfield, L.J., Bean, J.M., Prosnitz, L.R. and Dewhirst, M.W. (1996) Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. Cancer Res, 56, 941-943.
Bromke, B.J. and Kueppers, F. (1982) The major urinary protease inhibitor: simplified purification and characterization. Biochem Med, 27, 56-67.
Brown, J.M. (1999) The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. Cancer Res, 59, 5863-5870.
Brown, J.M. and Giaccia, A.J. (1998) The unique physiology of solid tumors: opportunities (and problems) for cancer therapy. Cancer Res, 58, 1408-1416.
Bruick, R.K. and McKnight, S.L. (2001) A conserved family of prolyl-4-hydroxylases that modify HIF. Science, 294, 1337-1340.
Cairns, R.A., Kalliomaki, T. and Hill, R.P. (2001) Acute (cyclic) hypoxia enhances spontaneous metastasis of KHT murine tumors. Cancer Res, 61, 8903-8908.
Catalona, W.J. and Smith, D.S. (1998) Cancer recurrence and survival rates after anatomic radical retropubic prostatectomy for prostate cancer: intermediate-term results. J Urol, 160, 2428-2434.
Ching, K.Z., Ramsey, E., Pettigrew, N., D'Cunha, R., Jason, M. and Dodd, J.G. (1993) Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines. Mol Cell Biochem, 126, 151-158.
Cirisano, F.D. and Karlan, B.Y. (1996) The role of the HER-2/neu oncogene in gynecologic cancers. J Soc Gynecol Investig, 3, 99-105.
Cuvier, C., Jang, A. and Hill, R.P. (1997) Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin Exp Metastasis, 15, 19-25.
Dang, C.V. and Semenza, G.L. (1999) Oncogenic alterations of metabolism. Trends Biochem Sci, 24, 68-72.
Demetriou, M., Nabi, I.R., Coppolino, M., Dedhar, S. and Dennis, J.W. (1995) Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J Cell Biol, 130, 383-392.
Dennis, J.W., Granovsky, M. and Warren, C.E. (1999) Glycoprotein glycosylation and cancer progression. Biochim Biophys Acta, 1473, 21-34.
Dennis, J.W., Laferte, S., Waghorne, C., Breitman, M.L. and Kerbel, R.S. (1987) Beta 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science, 236, 582-585.
Diarra-Mehrpour, M., Bourguignon, J., Sesboue, R., Salier, J.P., Leveillard, T. and Martin, J.P. (1990) Structural analysis of the human inter-alpha-trypsin inhibitor light-chain gene. Eur J Biochem, 191, 131-139.
Dillard, G.H. (1950) The trypsin inhibitor of the urine in health and disease. J Lab Clin Med, 36, 266-271.
Dosaka-Akita, H., Miyoshi, E., Suzuki, O., Itoh, T., Katoh, H. and Taniguchi, N. (2004) Expression of N-acetylglucosaminyltransferase v is associated with prognosis and histology in non-small cell lung cancers. Clin Cancer Res, 10, 1773-1779.
Faarvang, H.J. (1965) Physiological and patho-physiological variations, relation to pituitary-adrenocortical hormones, and to serum trypsin inhibitor. Scand J Clin Lab Invest, 17, Suppl 83:81-78.
Folkman, J. (1990) What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst, 82, 4-6.
Fritz, H., Heimburger, N., Meier, M., Arnhold, M., Zaneveld, L.J. and Schumacher, G.F. (1972) [Human acrosin: kinetics of the inhibition by inhibitors from human sera]. Hoppe Seylers Z Physiol Chem, 353, 1953-1956.
Galang, C.K., Garcia-Ramirez, J., Solski, P.A., Westwick, J.K., Der, C.J., Neznanov, N.N., Oshima, R.G. and Hauser, C.A. (1996) Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem, 271, 7992-7998.
Gaylis, F.D., Keer, H.N., Wilson, M.J., Kwaan, H.C., Sinha, A.A. and Kozlowski, J.M. (1989) Plasminogen activators in human prostate cancer cell lines and tumors: correlation with the aggressive phenotype. J Urol, 142, 193-198.
Gebhard, W., Hochstrasser, K., Fritz, H., Enghild, J.J., Pizzo, S.V. and Salvesen, G. (1990) Structure of inter-alpha-inhibitor (inter-alpha-trypsin inhibitor) and pre-alpha-inhibitor: current state and proposition of a new terminology. Biol Chem Hoppe Seyler, 371 Suppl, 13-22.
Gleason, D.F. and Mellinger, G.T. (1974) Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging. J Urol, 111, 58-64.
Graham, C.H., Forsdike, J., Fitzgerald, C.J. and Macdonald-Goodfellow, S. (1999) Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression. Int J Cancer, 80, 617-623.
Granovsky, M., Fata, J., Pawling, J., Muller, W.J., Khokha, R. and Dennis, J.W. (2000) Suppression of tumor growth and metastasis in Mgat5-deficient mice. Nat Med, 6, 306-312.
Guo, H.B., Lee, I., Kamar, M., Akiyama, S.K. and Pierce, M. (2002) Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res, 62, 6837-6845.
Hakomori, S. (1989) Aberrant glycosylation in tumors and tumor-associated carbohydrate antigens. Adv Cancer Res, 52, 257-331.
Hanahan, D. and Folkman, J. (1996) Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell, 86, 353-364.
Harris, A.L. (2002) Hypoxia--a key regulatory factor in tumour growth. Nat Rev Cancer, 2, 38-47.
Hochstrasser, K., Albrecht, G., Schonberger, O.L. and Wachter, E. (1983) Kunitz-type proteinase inhibitors derived by limited proteolysis of the inter-alpha-trypsin inhibitor, VII. Characterization of the bovine inhibitor as double-headed trypsin-elastase inhibitor. Hoppe Seylers Z Physiol Chem, 364, 1689-1696.
Hockel, M., Schlenger, K., Aral, B., Mitze, M., Schaffer, U. and Vaupel, P. (1996) Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. Cancer Res, 56, 4509-4515.
Holschneider, C.H. and Berek, J.S. (2000) Ovarian cancer: epidemiology, biology, and prognostic factors. Semin Surg Oncol, 19, 3-10.
Hooper, J.D., Clements, J.A., Quigley, J.P. and Antalis, T.M. (2001) Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem, 276, 857-860.
Horoszewicz, J.S., Leong, S.S., Kawinski, E., Karr, J.P., Rosenthal, H., Chu, T.M., Mirand, E.A. and Murphy, G.P. (1983) LNCaP model of human prostatic carcinoma. Cancer Res, 43, 1809-1818.
Hullinger, T.G., McCauley, L.K., DeJoode, M.L. and Somerman, M.J. (1998) Effect of bone proteins on human prostate cancer cell lines in vitro. Prostate, 36, 14-22.
Ihara, S., Miyoshi, E., Ko, J.H., Murata, K., Nakahara, S., Honke, K., Dickson, R.B., Lin, C.Y. and Taniguchi, N. (2002) Prometastatic effect of N-acetylglucosaminyltransferase V is due to modification and stabilization of active matriptase by adding beta 1-6 GlcNAc branching. J Biol Chem, 277, 16960-16967.
Ito, Y., Akinaga, A., Yamanaka, K., Nakagawa, T., Kondo, A., Dickson, R.B., Lin, C.Y., Miyauchi, A., Taniguchi, N. and Miyoshi, E. (2006) Co-expression of matriptase and N-acetylglucosaminyltransferase V in thyroid cancer tissues--its possible role in prolonged stability in vivo by aberrant glycosylation. Glycobiology, 16, 368-374.
Ito, Y., Miyoshi, E., Sakon, M., Takeda, T., Noda, K., Tsujimoto, M., Ito, S., Honda, H., Takemura, F., Wakasa, K., Monden, M., Matsuura, N. and Taniguchi, N. (2001) Elevated expression of UDP-N-acetylglucosamine: alphamannoside beta1,6 N-acetylglucosaminyltransferase is an early event in hepatocarcinogenesis. Int J Cancer, 91, 631-637.
Jonsson, B.M., Loffler, C. and Ohlsson, K. (1982) Human granulocyte elastase is inhibited by the urinary trypsin inhibitor. Hoppe Seylers Z Physiol Chem, 363, 1167-1175.
Kaighn, M.E., Narayan, K.S., Ohnuki, Y., Lechner, J.F. and Jones, L.W. (1979) Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Invest Urol, 17, 16-23.
Kanoh, Y., Akahoshi, T., Ohara, T., Ohtani, N., Mashiko, T., Ohtani, S., Egawa, S. and Baba, S. (2002) Expression of matrix metalloproteinase-2 and prostate-specific antigen in localized and metastatic prostate cancer. Anticancer Res, 22, 1813-1817.
Kitamoto, Y., Veile, R.A., Donis-Keller, H. and Sadler, J.E. (1995) cDNA sequence and chromosomal localization of human enterokinase, the proteolytic activator of trypsinogen. Biochemistry, 34, 4562-4568.
Kobayashi, H., Shinohara, H., Takeuchi, K., Itoh, M., Fujie, M., Saitoh, M. and Terao, T. (1994) Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis. Cancer Res, 54, 844-849.
Lambin, P., Fine, J.M. and Steinbuch, M. (1978) Inhibition of plasmin by a small molecular weight inhibitor derived from human inter alpha trypsin inhibitor. Thromb Res, 13, 563-568.
Lee, S.H., Wolf, P.L., Escudero, R., Deutsch, R., Jamieson, S.W. and Thistlethwaite, P.A. (2000a) Early expression of angiogenesis factors in acute myocardial ischemia and infarction. N Engl J Med, 342, 626-633.
Lee, S.L., Dickson, R.B. and Lin, C.Y. (2000b) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem, 275, 36720-36725.
Leytus, S.P., Loeb, K.R., Hagen, F.S., Kurachi, K. and Davie, E.W. (1988) A novel trypsin-like serine protease (hepsin) with a putative transmembrane domain expressed by human liver and hepatoma cells. Biochemistry, 27, 1067-1074.
Lieberman, R. (2004) Evidence-based medical perspectives: the evolving role of PSA for early detection, monitoring of treatment response, and as a surrogate end point of efficacy for interventions in men with different clinical risk states for the prevention and progression of prostate cancer. Am J Ther, 11, 501-506.
Lin, C.Y., Anders, J., Johnson, M., Sang, Q.A. and Dickson, R.B. (1999) Molecular cloning of cDNA for matriptase, a matrix-degrading serine protease with trypsin-like activity. J Biol Chem, 274, 18231-18236.
Lin, C.Y., Wang, J.K., Torri, J., Dou, L., Sang, Q.A. and Dickson, R.B. (1997) Characterization of a novel, membrane-bound, 80-kDa matrix-degrading protease from human breast cancer cells. Monoclonal antibody production, isolation, and localization. J Biol Chem, 272, 9147-9152.
Look, M.P. and Foekens, J.A. (1999) Clinical relevance of the urokinase plasminogen activator system in breast cancer. Apmis, 107, 150-159.
Matthews, N.E., Adams, M.A., Maxwell, L.R., Gofton, T.E. and Graham, C.H. (2001) Nitric oxide-mediated regulation of chemosensitivity in cancer cells. J Natl Cancer Inst, 93, 1879-1885.
Maxwell, P.H., Wiesener, M.S., Chang, G.W., Clifford, S.C., Vaux, E.C., Cockman, M.E., Wykoff, C.C., Pugh, C.W., Maher, E.R. and Ratcliffe, P.J. (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature, 399, 271-275.
Mignatti, P. and Rifkin, D.B. (1993) Biology and biochemistry of proteinases in tumor invasion. Physiol Rev, 73, 161-195.
Mignatti, P. and Rifkin, D.B. (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein, 49, 117-137.
Miyake, H., Hara, I., Yamanaka, K., Gohji, K., Arakawa, S. and Kamidono, S. (1999) Elevation of serum levels of urokinase-type plasminogen activator and its receptor is associated with disease progression and prognosis in patients with prostate cancer. Prostate, 39, 123-129.
Nishikawa, A., Gu, J., Fujii, S. and Taniguchi, N. (1990) Determination of N-acetylglucosaminyltransferases III, IV and V in normal and hepatoma tissues of rats. Biochim Biophys Acta, 1035, 313-318.
Paoloni-Giacobino, A., Chen, H., Peitsch, M.C., Rossier, C. and Antonarakis, S.E. (1997) Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3. Genomics, 44, 309-320.
Rademacher, T.W., Parekh, R.B. and Dwek, R.A. (1988) Glycobiology. Annu Rev Biochem, 57, 785-838.
Roscigno, M., Sangalli, M., Mazzoccoli, B., Scattoni, V., Da Pozzo, L. and Rigatti, P. (2005) Medical therapy of prostate cancer. A review. Minerva Urol Nefrol, 57, 71-84.
Ryan, H.E., Lo, J. and Johnson, R.S. (1998) HIF-1 alpha is required for solid tumor formation and embryonic vascularization. Embo J, 17, 3005-3015.
Saito, H., Gu, J., Nishikawa, A., Ihara, Y., Fujii, J., Kohgo, Y. and Taniguchi, N. (1995) Organization of the human N-acetylglucosaminyltransferase V gene. Eur J Biochem, 233, 18-26.
Salceda, S. and Caro, J. (1997) Hypoxia-inducible factor 1alpha (HIF-1alpha) protein is rapidly degraded by the ubiquitin-proteasome system under normoxic conditions. Its stabilization by hypoxia depends on redox-induced changes. J Biol Chem, 272, 22642-22647.
Semenza, G.L. (2002) Involvement of hypoxia-inducible factor 1 in human cancer. Intern Med, 41, 79-83.
Shi, Y.E., Torri, J., Yieh, L., Wellstein, A., Lippman, M.E. and Dickson, R.B. (1993) Identification and characterization of a novel matrix-degrading protease from hormone-dependent human breast cancer cells. Cancer Res, 53, 1409-1415.
Shikimi, T., Himeno, Y., Shigeno, K., Gonda, T., Ishibe, T., Hattori, K. and Takaori, S. (1994) Relationships between ulinastatin and alpha-1-microglobulin in human urine. Clin Chim Acta, 227, 195-200.
Shoreibah, M., Perng, G.S., Adler, B., Weinstein, J., Basu, R., Cupples, R., Wen, D., Browne, J.K., Buckhaults, P., Fregien, N. and et al. (1993) Isolation, characterization, and expression of a cDNA encoding N-acetylglucosaminyltransferase V. J Biol Chem, 268, 15381-15385.
Sinha, A.A., Quast, B.J., Wilson, M.J., Fernandes, E.T., Reddy, P.K., Ewing, S.L. and Gleason, D.F. (2002) Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Cancer, 94, 3141-3149.
Stetler-Stevenson, W.G., Hewitt, R. and Corcoran, M. (1996) Matrix metalloproteinases and tumor invasion: from correlation and causality to the clinic. Semin Cancer Biol, 7, 147-154.
Stone, K.R., Mickey, D.D., Wunderli, H., Mickey, G.H. and Paulson, D.F. (1978) Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer, 21, 274-281.
Sugiki, M., Sumi, H., Maruyama, M., Yoshida, E. and Mihara, H. (1989) Clearance and distribution of acid-stable trypsin inhibitor (ASTI). Enzyme, 42, 31-38.
Sutter, C.H., Laughner, E. and Semenza, G.L. (2000) Hypoxia-inducible factor 1alpha protein expression is controlled by oxygen-regulated ubiquitination that is disrupted by deletions and missense mutations. Proc Natl Acad Sci U S A, 97, 4748-4753.
Suzuki, M., Kobayashi, H., Kanayama, N., Saga, Y., Suzuki, M., Lin, C.Y., Dickson, R.B. and Terao, T. (2004) Inhibition of tumor invasion by genomic down-regulation of matriptase through suppression of activation of receptor-bound pro-urokinase. J Biol Chem, 279, 14899-14908.
Takei, Y., Mizukami, H., Saga, Y., Kobayashi, H., Suzuki, M., Matsushita, T., Ozawa, K. and Suzuki, M. (2005) Overexpression of a hybrid gene consisting of the amino-terminal fragment of urokinase and carboxyl-terminal domain of bikunin suppresses invasion and migration of human ovarian cancer cells in vitro. Int J Cancer, 113, 54-58.
Takeuchi, T., Shuman, M.A. and Craik, C.S. (1999) Reverse biochemistry: use of macromolecular protease inhibitors to dissect complex biological processes and identify a membrane-type serine protease in epithelial cancer and normal tissue. Proc Natl Acad Sci U S A, 96, 11054-11061.
Tanaka, Y., Maehara, S., Sumi, H., Toki, N., Moriyama, S. and Sasaki, K. (1982) Purification and partial characterization of two forms of urinary trypsin inhibitor. Biochim Biophys Acta, 705, 192-199.
Tanimoto, H., Underwood, L.J., Wang, Y., Shigemasa, K., Parmley, T.H. and O'Brien, T.J. (2001) Ovarian tumor cells express a transmembrane serine protease: a potential candidate for early diagnosis and therapeutic intervention. Tumour Biol, 22, 104-114.
Turner, T., Chen, P., Goodly, L.J. and Wells, A. (1996) EGF receptor signaling enhances in vivo invasiveness of DU-145 human prostate carcinoma cells. Clin Exp Metastasis, 14, 409-418.
Unruh, A., Ressel, A., Mohamed, H.G., Johnson, R.S., Nadrowitz, R., Richter, E., Katschinski, D.M. and Wenger, R.H. (2003) The hypoxia-inducible factor-1 alpha is a negative factor for tumor therapy. Oncogene, 22, 3213-3220.
Vetr, H. and Gebhard, W. (1990) Structure of the human alpha 1-microglobulin-bikunin gene. Biol Chem Hoppe Seyler, 371, 1185-1196.
Wallrapp, C., Hahnel, S., Muller-Pillasch, F., Burghardt, B., Iwamura, T., Ruthenburger, M., Lerch, M.M., Adler, G. and Gress, T.M. (2000) A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res, 60, 2602-2606.
Wang, G.L. and Semenza, G.L. (1993) General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia. Proc Natl Acad Sci U S A, 90, 4304-4308.
Wasylyk, B., Hagman, J. and Gutierrez-Hartmann, A. (1998) Ets transcription factors: nuclear effectors of the Ras-MAP-kinase signaling pathway. Trends Biochem Sci, 23, 213-216.
Weijerman, P.C., Konig, J.J., Wong, S.T., Niesters, H.G. and Peehl, D.M. (1994) Lipofection-mediated immortalization of human prostatic epithelial cells of normal and malignant origin using human papillomavirus type 18 DNA. Cancer Res, 54, 5579-5583.
Xie, H., Turner, T., Wang, M.H., Singh, R.K., Siegal, G.P. and Wells, A. (1995) In vitro invasiveness of DU-145 human prostate carcinoma cells is modulated by EGF receptor-mediated signals. Clin Exp Metastasis, 13, 407-419.
Yamaoka, K., Masuda, K., Ogawa, H., Takagi, K., Umemoto, N. and Yasuoka, S. (1998) Cloning and characterization of the cDNA for human airway trypsin-like protease. J Biol Chem, 273, 11895-11901.
Yan, S., Sameni, M. and Sloane, B.F. (1998) Cathepsin B and human tumor progression. Biol Chem, 379, 113-123.
Yan, W., Sheng, N., Seto, M., Morser, J. and Wu, Q. (1999) Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem, 274, 14926-14935.
Yonemura, Y., Nojima, N., Kaji, M., Fujimura, T., Itoh, H., Ninomiya, I., Miyazaki, I., Endo, Y. and Sasaki, T. (1995) E-cadherin and urokinase-type plasminogen activator tissue status in gastric carcinoma. Cancer, 76, 941-953.
Young, S.D., Marshall, R.S. and Hill, R.P. (1988) Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells. Proc Natl Acad Sci U S A, 85, 9533-9537.
Zagzag, D., Zhong, H., Scalzitti, J.M., Laughner, E., Simons, J.W. and Semenza, G.L. (2000) Expression of hypoxia-inducible factor 1alpha in brain tumors: association with angiogenesis, invasion, and progression. Cancer, 88, 2606-2618.
Zhang, Y., Cai, X., Schlegelberger, B. and Zheng, S. (1998) Assignment1 of human putative tumor suppressor genes ST13 (alias SNC6) and St14 (alias SNC19) to human chromosome bands 22q13 and 11q24-->q25 by in situ hybridization. Cytogenet Cell Genet, 83, 56-57.
Zhong, H., De Marzo, A.M., Laughner, E., Lim, M., Hilton, D.A., Zagzag, D., Buechler, P., Isaacs, W.B., Semenza, G.L. and Simons, J.W. (1999) Overexpression of hypoxia-inducible factor 1alpha in common human cancers and their metastases. Cancer Res, 59, 5830-5835.
Zolfaghari, A. and Djakiew, D. (1996) Inhibition of chemomigration of a human prostatic carcinoma cell (TSU-pr1) line by inhibition of epidermal growth factor receptor function. Prostate, 28, 232-238.
|